EP3027598
Oxókínasólínýl-bútanamíð afleiður
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
10.7.2014EP published:
12.4.2017EP application number:
14739045.4
EP translation filed:
1.6.2017Grant published:
15.6.2017EPO information:
European Patent Register
Max expiry date:
9.7.2034Expiry date:
9.7.2023
Title:
OXOQUINAZOLINYL-BUTANAMIDE DERIVATIVES
Timeline
Today
10.7.2014EP application
12.4.2017EP Publication
1.6.2017Translation submitted
15.6.2017Registration published
9.7.2023Expires
Owner
Name:
Merck Patent GmbHAddress:
Frankfurter Strasse 250, 64293, Darmstadt, DE
Inventor
Name:
DORSCH, DieterAddress:
Ober-Ramstadt, DE
Name:
BUCHSTALLER, Hans-PeterAddress:
Griesheim, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
13003815Date:
31.7.2013Country:
EP
Classification
Categories:
C07D 401/14, C07D 413/14, C07D 401/06, A61K 31/517, A61P 9/00, A61P 25/00, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 7.6.2017
Expires: 9.7.2018
Payer: Árnason Faktor
Number: 5
Paid: 7.6.2018
Expires: 9.7.2019
Payer: Árnason Faktor
Number: 6
Paid: 5.6.2019
Expires: 9.7.2020
Payer: Árnason Faktor
Number: 7
Paid: 12.6.2020
Expires: 9.7.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.6.2021
Expires: 9.7.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 9.6.2022
Expires: 9.7.2023
Payer: Árnason Faktor ehf.